Cargando…

Fertility drugs, reproductive strategies and ovarian cancer risk

Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomao, Federica, Lo Russo, Giuseppe, Spinelli, Gian Paolo, Stati, Valeria, Prete, Alessandra Anna, Prinzi, Natalie, Sinjari, Marsela, Vici, Patrizia, Papa, Anselmo, Chiotti, Maria Stefania, Benedetti Panici, Pierluigi, Tomao, Silverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020377/
https://www.ncbi.nlm.nih.gov/pubmed/24829615
http://dx.doi.org/10.1186/1757-2215-7-51
_version_ 1782316058779058176
author Tomao, Federica
Lo Russo, Giuseppe
Spinelli, Gian Paolo
Stati, Valeria
Prete, Alessandra Anna
Prinzi, Natalie
Sinjari, Marsela
Vici, Patrizia
Papa, Anselmo
Chiotti, Maria Stefania
Benedetti Panici, Pierluigi
Tomao, Silverio
author_facet Tomao, Federica
Lo Russo, Giuseppe
Spinelli, Gian Paolo
Stati, Valeria
Prete, Alessandra Anna
Prinzi, Natalie
Sinjari, Marsela
Vici, Patrizia
Papa, Anselmo
Chiotti, Maria Stefania
Benedetti Panici, Pierluigi
Tomao, Silverio
author_sort Tomao, Federica
collection PubMed
description Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer.
format Online
Article
Text
id pubmed-4020377
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40203772014-05-15 Fertility drugs, reproductive strategies and ovarian cancer risk Tomao, Federica Lo Russo, Giuseppe Spinelli, Gian Paolo Stati, Valeria Prete, Alessandra Anna Prinzi, Natalie Sinjari, Marsela Vici, Patrizia Papa, Anselmo Chiotti, Maria Stefania Benedetti Panici, Pierluigi Tomao, Silverio J Ovarian Res Review Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer. BioMed Central 2014-05-08 /pmc/articles/PMC4020377/ /pubmed/24829615 http://dx.doi.org/10.1186/1757-2215-7-51 Text en Copyright © 2014 Tomao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Tomao, Federica
Lo Russo, Giuseppe
Spinelli, Gian Paolo
Stati, Valeria
Prete, Alessandra Anna
Prinzi, Natalie
Sinjari, Marsela
Vici, Patrizia
Papa, Anselmo
Chiotti, Maria Stefania
Benedetti Panici, Pierluigi
Tomao, Silverio
Fertility drugs, reproductive strategies and ovarian cancer risk
title Fertility drugs, reproductive strategies and ovarian cancer risk
title_full Fertility drugs, reproductive strategies and ovarian cancer risk
title_fullStr Fertility drugs, reproductive strategies and ovarian cancer risk
title_full_unstemmed Fertility drugs, reproductive strategies and ovarian cancer risk
title_short Fertility drugs, reproductive strategies and ovarian cancer risk
title_sort fertility drugs, reproductive strategies and ovarian cancer risk
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020377/
https://www.ncbi.nlm.nih.gov/pubmed/24829615
http://dx.doi.org/10.1186/1757-2215-7-51
work_keys_str_mv AT tomaofederica fertilitydrugsreproductivestrategiesandovariancancerrisk
AT lorussogiuseppe fertilitydrugsreproductivestrategiesandovariancancerrisk
AT spinelligianpaolo fertilitydrugsreproductivestrategiesandovariancancerrisk
AT stativaleria fertilitydrugsreproductivestrategiesandovariancancerrisk
AT pretealessandraanna fertilitydrugsreproductivestrategiesandovariancancerrisk
AT prinzinatalie fertilitydrugsreproductivestrategiesandovariancancerrisk
AT sinjarimarsela fertilitydrugsreproductivestrategiesandovariancancerrisk
AT vicipatrizia fertilitydrugsreproductivestrategiesandovariancancerrisk
AT papaanselmo fertilitydrugsreproductivestrategiesandovariancancerrisk
AT chiottimariastefania fertilitydrugsreproductivestrategiesandovariancancerrisk
AT benedettipanicipierluigi fertilitydrugsreproductivestrategiesandovariancancerrisk
AT tomaosilverio fertilitydrugsreproductivestrategiesandovariancancerrisk